Buccal Midazolam Versus Nasal or Oral Midazolam Sedation for Minor Invasive Procedures in Children
1 other identifier
interventional
90
1 country
1
Brief Summary
Currently Midazolam sedation is the standard of care for minor invasive procedures in pediatric patients; its use is restricted to two routes of administration for this purpose oral and intranasal. A third route of administration (buccal) is tested and approved for seizure management. In the investigators' study the researchers investigate the buccal route of administration versus oral or intranasal administration for sedation. The investigators' hypothesis is that buccal route of administration is more convenient than intranasal and better absorbed than oral.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Apr 2015
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedApril 9, 2015
March 1, 2015
10 months
March 31, 2015
April 8, 2015
Conditions
Outcome Measures
Primary Outcomes (4)
time until sedation is achieved
1 hour
duration of sedation
time from achieving sedation until reaching full consciousness
4 hour
convenience of administration
described by the parent and the physician by a numerical rating scale (NRS) questionaire
15 minutes
efficacy of the sedation
described by the parent, nurse and physician by a NRS questionaire
4 hours
Study Arms (3)
oral midazolam
ACTIVE COMPARATORoral midazolam 0.5-0.7 mg/kg maximum 10 mg. one dose only before the invasive procedure.
intranasal midazolam
ACTIVE COMPARATORintranasal midazolam 0.3-0.5 mg/kg maximum 5 mg. one dose only before the invasive procedure
buccal midazolam
ACTIVE COMPARATORbuccal midazolam 0.3-0.5 mg/kg maximum 5 mg. one dose only before the invasive procedure
Interventions
comparison between 3 routes of administration of the drug Midazolam used for sedation for minor procedures in pediatric population. the routes are oral intranasal and buccal.
Eligibility Criteria
You may qualify if:
- age 5 months to 6 years.
- need to undergo a minimal invasive procedure that requires light sedation.
- ASA (American Society of Anesthesiologists) I-II
- parent that can read, understand and sign an informed consent form
You may not qualify if:
- patients with life threatening conditions.
- patients with respiratory or cardiac chronic illnesses or ASA other than I-II.
- patients with traumatic injury for the nose or the oral cavity.
- patients that would not or cannot take the drug in the route picked in a randomized way.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carmel Medical Center
Haifa, Israel
Related Publications (11)
Krauss B, Green SM. Sedation and analgesia for procedures in children. N Engl J Med. 2000 Mar 30;342(13):938-45. doi: 10.1056/NEJM200003303421306. No abstract available.
PMID: 10738053BACKGROUNDKrauss B, Green SM. Procedural sedation and analgesia in children. Lancet. 2006 Mar 4;367(9512):766-80. doi: 10.1016/S0140-6736(06)68230-5.
PMID: 16517277BACKGROUNDAmerican Academy of Pediatrics; American Academy of Pediatric Dentistry; Cote CJ, Wilson S; Work Group on Sedation. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update. Pediatrics. 2006 Dec;118(6):2587-602. doi: 10.1542/peds.2006-2780.
PMID: 17142550BACKGROUNDProcacci P, Francini F, Zoppi M, Maresca M. Cutaneous pain threshold changes after sympathetic block in reflex dystrophies. Pain. 1975 Jun;1(2):167-175. doi: 10.1016/0304-3959(75)90100-1.
PMID: 1235980BACKGROUNDAmerican Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002 Apr;96(4):1004-17. doi: 10.1097/00000542-200204000-00031. No abstract available.
PMID: 11964611BACKGROUNDGodwin SA, Caro DA, Wolf SJ, Jagoda AS, Charles R, Marett BE, Moore J; American College of Emergency Physicians. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2005 Feb;45(2):177-96. doi: 10.1016/j.annemergmed.2004.11.002. No abstract available.
PMID: 15671976BACKGROUNDShavit I, Feraru L, Miron D, Weiser G. Midazolam for urethral catheterisation in female infants with suspected urinary tract infection: a case-control study. Emerg Med J. 2014 Apr;31(4):278-80. doi: 10.1136/emermed-2012-202088. Epub 2013 Feb 22.
PMID: 23435653BACKGROUNDMcErlean M, Bartfield JM, Karunakar TA, Whitman MC, Turley DM. Midazolam syrup as a premedication to reduce the discomfort associated with pediatric intravenous catheter insertion. J Pediatr. 2003 Apr;142(4):429-30. doi: 10.1067/mpd.2003.62.
PMID: 12712062BACKGROUNDLane RD, Schunk JE. Atomized intranasal midazolam use for minor procedures in the pediatric emergency department. Pediatr Emerg Care. 2008 May;24(5):300-3. doi: 10.1097/PEC.0b013e31816ecb6f.
PMID: 18496113BACKGROUNDWiznitzer M. Buccal midazolam is effective for acute treatment of seizures. J Pediatr. 2006 Jan;148(1):143. doi: 10.1016/j.jpeds.2005.12.008. No abstract available.
PMID: 16440479BACKGROUNDWiznitzer M. Buccal midazolam for seizures. Lancet. 2005 Jul 16-22;366(9481):182-3. doi: 10.1016/S0140-6736(05)66884-5. No abstract available.
PMID: 16023491BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muriel Konopnicki
Carmal Medical Center, Haifa, Israel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Pediatric emergency room
Study Record Dates
First Submitted
March 31, 2015
First Posted
April 3, 2015
Study Start
April 1, 2015
Primary Completion
February 1, 2016
Study Completion
March 1, 2016
Last Updated
April 9, 2015
Record last verified: 2015-03